27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CD6 modulates thymocyte selection and peripheral T cell homeostasis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Orta-Mascaró, Lozano, and collaborators provide the first analysis of CD6-deficient mice, showing that this molecule modulates T cell receptor signaling and the threshold for thymocyte and peripheral T cell subset selection.

          Abstract

          The CD6 glycoprotein is a lymphocyte surface receptor putatively involved in T cell development and activation. CD6 facilitates adhesion between T cells and antigen-presenting cells through its interaction with CD166/ALCAM (activated leukocyte cell adhesion molecule), and physically associates with the T cell receptor (TCR) at the center of the immunological synapse. However, its precise role during thymocyte development and peripheral T cell immune responses remains to be defined. Here, we analyze the in vivo consequences of CD6 deficiency. CD6 −/− thymi showed a reduction in both CD4 + and CD8 + single-positive subsets, and double-positive thymocytes exhibited increased Ca 2+ mobilization to TCR cross-linking in vitro. Bone marrow chimera experiments revealed a T cell–autonomous selective disadvantage of CD6 −/− T cells during development. The analysis of TCR-transgenic mice (OT-I and Marilyn) confirmed that abnormal T cell selection events occur in the absence of CD6. CD6 −/− mice displayed increased frequencies of antigen-experienced peripheral T cells generated under certain levels of TCR signal strength or co-stimulation, such as effector/memory (CD4 +T EM and CD8 +T CM) and regulatory (T reg) T cells. The suppressive activity of CD6 −/− T reg cells was diminished, and CD6 −/− mice presented an exacerbated autoimmune response to collagen. Collectively, these data indicate that CD6 modulates the threshold for thymocyte selection and the generation and/or function of several peripheral T cell subpopulations, including T reg cells.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Understanding the generation and function of memory T cell subsets.

          Memory T cells can be broadly divided into central memory and effector memory subsets, which are endowed with different capacities to home to lymphoid or non-lymphoid tissues, to proliferate in response to antigen or cytokines and to perform effector functions. In the past few years progress has been made in understanding the properties of these memory T cell subsets and, in particular, the signals required for their generation and maintenance. Collectively these data point to a critical role of central memory T cells in conferring long-term immunity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A role for CD5 in TCR-mediated signal transduction and thymocyte selection.

            CD5 is a transmembrane protein that is expressed on the surface of T cells and a subset of B cells. The absence of CD5 rendered thymocytes hyperresponsive to stimulation through the T cell antigen receptor (TCR) in vitro. Selection of T cells expressing three distinct transgenic TCRs was also abnormal in CD5-deficient mice. These observations indicate that CD5 can influence the fate of developing thymocytes by acting as a negative regulator of TCR-mediated signal transduction.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection.

              The present report provides the first extensive characterization of the OT-I TCR transgenic line, which produces MHC class I-restricted, ovalbumin-specific, CD8+ T cells (OT-I cells). These cells are shown to be positively selected in vivo in H-2b C57BL/6 mice and in bm5 mice, which express the Kbm5 mutant molecule. In contrast, OT-I cells were not selected by mutant Kb molecules in bm1, bm3, bm8, bm10, bm11 or bm23 mice. Interestingly, however, when positive selection was examined in vitro in foetal thymic organ culture (FTOC), bm1 and bm8 were still poorly selective, but the bm3 haplotype now selected as efficiently as B6. The ability to select in vitro correlated with the capacity to present the ovalbumin (OVA) peptide to OT-I cells, as measured by induction of an OVA-specific proliferative response. These results suggest that a lower affinity TCR:MHC interaction may be necessary for positive selection in FTOC compared with selection in situ.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                25 July 2016
                : 213
                : 8
                : 1387-1397
                Affiliations
                [1 ]Institut d’Investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain
                [2 ]Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Institut National de la Santé et de la Recherche Médicale, U1104, Centre National de la Recherche Scientifique UMR7280, 13402 Marseille, France
                [3 ]Universitat Pompeu Fabra, 08002 Barcelona, Spain
                [4 ]Instituto de Biomedicina y Biotecnología de Cantabria, Consejo Superior de Investigaciones Científicas-Universidad de Cantabria, 39005 Santander, Spain
                [5 ]Departmento de Biología Molecular, Universidad de Cantabria, Instituto de Investigación Sanitaria Valdecilla, 39011 Santander, Spain
                [6 ]Institut National de la Santé et de la Recherche Médicale, 75654 Paris, France
                [7 ]Servei d’Immunologia, Hospital Clínic de Barcelona, 08036 Barcelona, Spain
                [8 ]Departament de Biologia Cellular, Immunologia i Neurociències, Universitat de Barcelona, 08007 Barcelona, Spain
                Author notes
                Correspondence to Francisco Lozano: flozano@ 123456clinic.ub.es
                [*]

                M. Consuegra-Fernández, E. Carreras, and R. Roncagalli contributed equally to this paper.

                Author information
                http://orcid.org/0000-0003-4923-2083
                http://orcid.org/0000-0001-9184-8266
                http://orcid.org/0000-0001-7554-0552
                http://orcid.org/0000-0002-9032-5639
                http://orcid.org/0000-0002-6331-0933
                http://orcid.org/0000-0003-1730-7263
                http://orcid.org/0000-0002-5673-9803
                http://orcid.org/0000-0002-5306-0635
                http://orcid.org/0000-0003-0401-4808
                http://orcid.org/0000-0003-3476-1150
                http://orcid.org/0000-0003-1340-9342
                http://orcid.org/0000-0003-1119-4368
                Article
                20151785
                10.1084/jem.20151785
                4986531
                27377588
                698d4ec3-08eb-4e9b-8ce9-075504555fd5
                © 2016 Orta-Mascaró et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

                History
                : 12 November 2015
                : 18 May 2016
                Funding
                Funded by: Worldwide Cancer Research http://dx.doi.org/10.13039/501100007287
                Award ID: 14-1275
                Funded by: Fundació La Marató http://dx.doi.org/10.13039/100008666
                Award ID: 201319-30
                Funded by: Spanish Ministerio de Economía y Competitividad http://dx.doi.org/10.13039/501100003329
                Award ID: SAF2013-46151-R
                Award ID: SAF2012-34059
                Award ID: SAF2014-55088-R
                Award ID: SAF2014-52228-R
                Funded by: Centre National de la Recherche Scientifique http://dx.doi.org/10.13039/501100004794
                Funded by: Institut National de la Santé et de la Recherche Médicale http://dx.doi.org/10.13039/501100001677
                Funded by: European Research Council http://dx.doi.org/10.13039/501100000781
                Award ID: 322465
                Funded by: Ministerio de Economía y Competitividad http://dx.doi.org/10.13039/501100003329
                Award ID: BES-2011-048415
                Funded by: Fundação para a Ciência e a Tecnologia http://dx.doi.org/10.13039/501100001871
                Award ID: SFRH/BD/75738/2011
                Funded by: European Community Seventh Framework Program http://dx.doi.org/10.13039/501100004963
                Award ID: FP7/2007/2013;229673
                Award ID: National Institutes of Health
                Award ID: U01HG004085
                Categories
                Research Articles
                Brief Definitive Report

                Medicine
                Medicine

                Comments

                Comment on this article